← Back to feed
Breaches & RansomwareEmerging1 sourceAug 28, 2026 Ā· 15:02via Ransomware.live

šŸ“ā€ā˜ ļø Global has just published a new victim : Hangzhou Qihan Biotech Co., Ltd.

Brief

Qihan Biotech is a Hangzhou‑based biotech company specializing in gene editing and cell/organ therapies. It develops immune‑privileged cells and xenogeneic organs to treat cancer and organ failure. The company aims to make these therapies accessible worldwide.

Read more on Ransomware.live→